Efficacy and Safety of Subcutaneous Rocatinlimab in Adults With Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials.

Wang HJ, Wang LS, Tan JWL, Wang ES, Lee YY

Open source

DOI
10.1155/drp/2160445
Published
2026
Container
Dermatology research and practice
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1155/drp/2160445,
  title = {Efficacy and Safety of Subcutaneous Rocatinlimab in Adults With Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials.},
  author = {Wang HJ and Wang LS and Tan JWL and Wang ES and Lee YY},
  year = {2026},
  journal = {Dermatology research and practice},
  doi = {10.1155/drp/2160445},
  url = {https://doi.org/10.1155/drp/2160445}
}

RIS

TY  - JOUR
TI  - Efficacy and Safety of Subcutaneous Rocatinlimab in Adults With Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials.
AU  - Wang HJ
AU  - Wang LS
AU  - Tan JWL
AU  - Wang ES
AU  - Lee YY
PY  - 2026
JO  - Dermatology research and practice
DO  - 10.1155/drp/2160445
UR  - https://doi.org/10.1155/drp/2160445
ER  - 

APA

HJ, W., LS, W., JWL, T., ES, W., & YY, L. (2026). Efficacy and Safety of Subcutaneous Rocatinlimab in Adults With Moderate-to-Severe Atopic Dermatitis: A Systematic Review and Meta-Analysis of Randomised Placebo-Controlled Trials.. Dermatology research and practice. https://doi.org/10.1155/drp/2160445

Source records